L.T. Tanoue

18.8k total citations · 11 hit papers
206 papers, 12.8k citations indexed

About

L.T. Tanoue is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, L.T. Tanoue has authored 206 papers receiving a total of 12.8k indexed citations (citations by other indexed papers that have themselves been cited), including 128 papers in Pulmonary and Respiratory Medicine, 51 papers in Oncology and 39 papers in Surgery. Recurrent topics in L.T. Tanoue's work include Lung Cancer Diagnosis and Treatment (97 papers), Lung Cancer Treatments and Mutations (81 papers) and Radiomics and Machine Learning in Medical Imaging (30 papers). L.T. Tanoue is often cited by papers focused on Lung Cancer Diagnosis and Treatment (97 papers), Lung Cancer Treatments and Mutations (81 papers) and Radiomics and Machine Learning in Medical Imaging (30 papers). L.T. Tanoue collaborates with scholars based in United States, Australia and Greece. L.T. Tanoue's co-authors include Frank C. Detterbeck, Richard A. Matthay, Charles S. Dela Cruz, Daniel J. Boffa, Anthony W. Kim, Gerard A. Silvestri, Michael K. Gould, Mitchell L. Margolis, Loren J. Harris and Anne V. Gonzalez and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

L.T. Tanoue

196 papers receiving 12.5k citations

Hit Papers

Lung Cancer: Epidemiology, Etiology, and Prevention 2006 2026 2012 2019 2011 2007 2016 2013 2012 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Lung Cancer: Epidemiology, Etiology, and Prevention
    2011 1.9k citations Charles S. Dela Cruz, L.T. Tanoue et al. Clinics in Chest Medicine profile →
  2. Annual Smoking-Attributable Mortality, Years of Potential Life Lost, and Productivity Losses—United States, 1997–2001
    2007 1.2k citations L.T. Tanoue profile →
  3. The Eighth Edition Lung Cancer Stage Classification
    2016 1.1k citations Frank C. Detterbeck, Daniel J. Boffa et al. CHEST Journal profile →
  4. Methods for Staging Non-small Cell Lung Cancer
    2013 976 citations Gerard A. Silvestri, Michael K. Gould et al. CHEST Journal profile →
  5. New driver mutations in non-small-cell lung cancer
    2012 683 citations L.T. Tanoue profile →
  6. The New Lung Cancer Staging System
    2009 672 citations Frank C. Detterbeck, Daniel J. Boffa et al. CHEST Journal profile →
  7. Quitting Smoking Among Adults — United States, 2001–2010
    2012 633 citations L.T. Tanoue profile →
  8. EGFR Mutations in Lung Cancer: Correlation With Clinical Response to Gefitinib Therapy
    2006 500 citations L.T. Tanoue profile →
  9. Noninvasive Staging of Non-small Cell Lung Cancer
    2007 444 citations Gerard A. Silvestri, Michael K. Gould et al. CHEST Journal profile →
  10. Vital Signs: Current Cigarette Smoking Among Adults Aged ≥18Years — United States, 2009
    2011 429 citations L.T. Tanoue profile →
  11. The Proposed Ninth Edition TNM Classification of Lung Cancer
    2024 37 citations Frank C. Detterbeck, L.T. Tanoue et al. CHEST Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L.T. Tanoue United States 38 7.2k 3.7k 2.4k 1.8k 1.7k 206 12.8k
Juan P. Wisnivesky United States 54 4.6k 0.6× 2.5k 0.7× 1.3k 0.5× 752 0.4× 1.9k 1.1× 282 11.0k
Gregory R. Pond Canada 65 5.6k 0.8× 5.7k 1.5× 2.6k 1.1× 1.6k 0.9× 536 0.3× 575 15.8k
Lorelei A. Mucci United States 69 5.3k 0.7× 3.5k 1.0× 3.6k 1.5× 529 0.3× 1.5k 0.9× 436 15.8k
Anna E. Barón United States 58 3.7k 0.5× 3.6k 1.0× 3.1k 1.3× 910 0.5× 450 0.3× 231 12.8k
Geertruida H. de Bock Netherlands 65 4.3k 0.6× 5.9k 1.6× 2.2k 0.9× 2.9k 1.6× 1.1k 0.7× 650 18.7k
James R. Jett United States 67 10.1k 1.4× 6.8k 1.9× 3.1k 1.3× 3.2k 1.8× 606 0.3× 277 16.6k
Neil E. Caporaso United States 72 3.6k 0.5× 4.3k 1.2× 7.0k 2.9× 734 0.4× 2.4k 1.4× 279 17.6k
Ryan Woods Canada 33 4.0k 0.6× 2.9k 0.8× 1.4k 0.6× 527 0.3× 1.4k 0.8× 116 8.9k
Jan‐Willem J. Lammers Netherlands 51 4.6k 0.6× 1.7k 0.4× 2.7k 1.1× 1.2k 0.7× 1.8k 1.0× 184 10.7k
Martin G. Sanda United States 57 10.2k 1.4× 3.9k 1.1× 4.7k 1.9× 1.2k 0.7× 794 0.5× 268 17.6k

Countries citing papers authored by L.T. Tanoue

Since Specialization
Citations

This map shows the geographic impact of L.T. Tanoue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.T. Tanoue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.T. Tanoue more than expected).

Fields of papers citing papers by L.T. Tanoue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L.T. Tanoue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.T. Tanoue. The network helps show where L.T. Tanoue may publish in the future.

Co-authorship network of co-authors of L.T. Tanoue

This figure shows the co-authorship network connecting the top 25 collaborators of L.T. Tanoue. A scholar is included among the top collaborators of L.T. Tanoue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.T. Tanoue. L.T. Tanoue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Henderson, Louise M., Roger Y. Kim, Nichole T. Tanner, et al.. (2025). Lung Cancer Screening and Incidental Findings: A Research Agenda: An Official American Thoracic Society Research Statement. American Journal of Respiratory and Critical Care Medicine. 211(3). 436–451. 3 indexed citations
2.
Detterbeck, Frank C., Ami N. Rubinowitz, Babina Gosangi, et al.. (2023). Lung cancer with air lucency: a systematic review and clinical management guide. Journal of Thoracic Disease. 15(2). 731–746. 10 indexed citations
3.
Bade, Brett C., Geliang Gan, Fangyong Li, et al.. (2021). “Randomized trial of physical activity on quality of life and lung cancer biomarkers in patients with advanced stage lung cancer: a pilot study”. BMC Cancer. 21(1). 352–352. 39 indexed citations
4.
Wu, Jing, Yihuan Lu, Mika Naganawa, et al.. (2018). Improved discrimination between benign and malignant LDCT screening-detected lung nodules with dynamic over static 18F-FDG PET as a function of injected dose. Physics in Medicine and Biology. 63(17). 175015–175015. 21 indexed citations
5.
Thomson, Carey C., Kristin A. Riekert, Carol K. Bates, et al.. (2018). Addressing Gender Inequality in Our Disciplines: Report from the Association of Pulmonary, Critical Care, and Sleep Division Chiefs. Annals of the American Thoracic Society. 15(12). 1382–1390. 16 indexed citations
6.
Rivera, M. Patricia, Nichole T. Tanner, Gerard A. Silvestri, et al.. (2018). Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement. American Journal of Respiratory and Critical Care Medicine. 198(2). e3–e13. 66 indexed citations
7.
Detterbeck, Frank C., Daniel J. Boffa, Anthony W. Kim, & L.T. Tanoue. (2016). The Eighth Edition Lung Cancer Stage Classification. CHEST Journal. 151(1). 193–203. 1121 indexed citations breakdown →
8.
Erb, Christopher T., et al.. (2016). Surveillance Practice Patterns after Curative Intent Therapy for Stage I Non-Small-Cell Lung Cancer in the Medicare Population. Lung Cancer. 99. 200–207. 12 indexed citations
9.
Cai, Shan, Li Qin, L.T. Tanoue, et al.. (2015). Effects of One-Hour Training Course and Spirometry on the Ability of Physicians to Diagnose and Treat Chronic Obstructive Pulmonary Disease. PLoS ONE. 10(2). e0117348–e0117348. 9 indexed citations
10.
Tanoue, L.T., Nichole T. Tanner, Michael K. Gould, & Gerard A. Silvestri. (2014). Lung Cancer Screening. American Journal of Respiratory and Critical Care Medicine. 191(1). 19–33. 179 indexed citations
11.
Erb, Christopher T., et al.. (2014). Surveillance Practice Patterns After Curative Intent Therapy for Stage I Non-small Cell Lung Cancer in the Medicare Population. CHEST Journal. 146(4). 607A–607A. 2 indexed citations
12.
Ost, David E., Sai‐Ching J. Yeung, L.T. Tanoue, & Michael K. Gould. (2013). Clinical and Organizational Factors in the Initial Evaluation of Patients With Lung Cancer. CHEST Journal. 143(5). e121S–e141S. 106 indexed citations
13.
Tanoue, L.T., Pamela R. Soulos, Anthony W. Kim, et al.. (2011). Thoroughness of Mediastinal Staging in Stage IIIA Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 7(1). 188–195. 15 indexed citations
14.
Cruz, Charles S. Dela, L.T. Tanoue, & Richard A. Matthay. (2011). Lung Cancer: Epidemiology, Etiology, and Prevention. Clinics in Chest Medicine. 32(4). 605–644. 1905 indexed citations breakdown →
15.
Anagnostou, Valsamo, Gerold Bepler, Konstantinos N. Syrigos, et al.. (2009). High Expression of Mammalian Target of Rapamycin Is Associated with Better Outcome for Patients with Early Stage Lung Adenocarcinoma. Clinical Cancer Research. 15(12). 4157–4164. 29 indexed citations
16.
Detterbeck, Frank C., Daniel J. Boffa, & L.T. Tanoue. (2009). The New Lung Cancer Staging System. CHEST Journal. 136(1). 260–271. 672 indexed citations breakdown →
17.
Kapoor, John R, et al.. (2007). Massive Intravascular Hemolysis and a Rapidly Fatal Outcome. CHEST Journal. 132(6). 2016–2019. 18 indexed citations
18.
Tanoue, L.T.. (2003). Pulmonary Hypertension in the Collagen Vascular Diseases. Seminars in Respiratory and Critical Care Medicine. 24(3). 287–296. 11 indexed citations
19.
Tanoue, L.T.. (2000). Preoperative Evaluation of the High-Risk Surgical Patient for Lung Cancer Resection. Seminars in Respiratory and Critical Care Medicine. Volume 21(Number 05). 421–432. 2 indexed citations
20.
Redlich, Carrie A., Ariëtte M. van Bennekum, Joel A. Wirth, et al.. (1995). Vitamin A Chemoprevention of Lung Cancer. Advances in experimental medicine and biology. 375. 17–29.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juan P. Wisnivesky Breakdown of academic impact, for papers by Gregory R. Pond Breakdown of academic impact, for papers by Lorelei A. Mucci Breakdown of academic impact, for papers by Anna E. Barón Breakdown of academic impact, for papers by Geertruida H. de Bock Breakdown of academic impact, for papers by James R. Jett Breakdown of academic impact, for papers by Neil E. Caporaso Breakdown of academic impact, for papers by Ryan Woods Breakdown of academic impact, for papers by Jan‐Willem J. Lammers Breakdown of academic impact, for papers by Martin G. Sanda
Rankless by CCL
2026